Literature DB >> 11896492

Soluble leptin receptor and insulin resistance as determinant of sleep apnea.

D Manzella1, M Parillo, T Razzino, P Gnasso, S Buonanno, A Gargiulo, M Caputi, G Paolisso.   

Abstract

OBJECTIVE: To investigate the possible associations between sleep apnea syndrome, hyperinsulinemia/insulin resistance and hyperleptinemia in subjects with different degrees of body mass index.
DESIGN: To test for the presence or absence of sleep apnea syndrome in association with hyperinsulinemia/insulin resistance and hyperleptinemia.
SUBJECTS: Twenty subjects with different body mass index (mean BMI 30.9+/-4.2). MEASUREMENTS: Insulin action and plasma soluble leptin receptor were measured by euglycemic hyperinsulinemic glucose clamp and by ELISA method, respectively. Occurrence of sleep apnea syndrome was assessed by clinical and nocturnal monitoring using a validated sleep apnea recorder.
RESULTS: The apnea/hypopnea index (AHI) was positively correlated with plasma soluble leptin receptor (0.76; P<0.001) and negatively with the degree of insulin-mediated glucose uptake (r=-0.73; P<0.001). In a multivariate analysis AHI was associated with plasma soluble leptin receptor and insulin mediated glucose uptake independently of age, gender, BMI, plasma leptin levels and PaCO(2).
CONCLUSION: Sleep apnea syndrome is associated with plasma soluble leptin receptor and insulin resistance independently of BMI.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11896492     DOI: 10.1038/sj.ijo.0801939

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  19 in total

Review 1.  Obstructive sleep apnea syndrome and asthma: what are the links?

Authors:  Michel Alkhalil; Edward Schulman; Joanne Getsy
Journal:  J Clin Sleep Med       Date:  2009-02-15       Impact factor: 4.062

2.  Sleep Apnea and Metabolic Dysfunction: Cause or Co-Relation?

Authors:  R Nisha Aurora; Naresh M Punjabi
Journal:  Sleep Med Clin       Date:  2007-06-01

3.  Sleep Apnea and its association with the Stress System, Inflammation, Insulin Resistance and Visceral Obesity.

Authors:  G Trakada; G Chrousos; S Pejovic; A Vgontzas
Journal:  Sleep Med Clin       Date:  2007-06

Review 4.  Obstructive Sleep Apnoea and Type 2 Diabetes.

Authors:  Abd A Tahrani; Asad Ali
Journal:  Eur Endocrinol       Date:  2014-02-28

5.  Effects of leptin and obesity on the upper airway function.

Authors:  Mikhael Polotsky; Ahmed S Elsayed-Ahmed; Luis Pichard; Christopher C Harris; Philip L Smith; Hartmut Schneider; Jason P Kirkness; Vsevolod Polotsky; Alan R Schwartz
Journal:  J Appl Physiol (1985)       Date:  2012-02-16

Review 6.  Effect of CPAP therapy on liver disease in patients with OSA: a review.

Authors:  Xin Liu; Yuyang Miao; Fan Wu; Tingting Du; Qiang Zhang
Journal:  Sleep Breath       Date:  2018-01-11       Impact factor: 2.816

7.  Obstructive sleep apnea and the metabolic syndrome in an elderly healthy population: the SYNAPSE cohort.

Authors:  Hourfil-Gabin Ntougou Assoumou; Jean-Michel Gaspoz; Emilia Sforza; Vincent Pichot; Sébastien Celle; Delphine Maudoux; Michel Kossovsky; Florian Chouchou; Jean-Claude Barthelemy; Frédéric Roche
Journal:  Sleep Breath       Date:  2011-09-18       Impact factor: 2.816

Review 8.  Hypothalamic orexins/hypocretins as regulators of breathing.

Authors:  Rhîannan H Williams; Denis Burdakov
Journal:  Expert Rev Mol Med       Date:  2008-10-02       Impact factor: 5.600

9.  Sleep and diabetes.

Authors:  Swetha Bopparaju; Salim Surani
Journal:  Int J Endocrinol       Date:  2010-03-09       Impact factor: 3.257

10.  No effect of 8-week time in bed restriction on glucose tolerance in older long sleepers.

Authors:  Mark R Zielinski; Christopher E Kline; Daniel F Kripke; Richard K Bogan; Shawn D Youngstedt
Journal:  J Sleep Res       Date:  2008-08-05       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.